We have located links that may give you full text access.
Dicarboxylic acids and related compounds in PM 2.5 aerosols in Huangshi, central China.
Journal of the Air & Waste Management Association 2018 December 11
PM2.5 samples were collected in Huangshi (HS), central China from March 2012 to February 2013 and were analyzed for dicarboxylic acids (diacids) and related compounds (DARCs). Oxalic acid (C2 , 416 ng m-3 ) was the most abundant species, followed by phthalic (Ph, 122 ng m-3 ), terephthalic (tPh, 116 ng m-3 ), succinic (C4 , 70.4 ng m-3 ), azelaic (C9 , 67.9 ng m-3 ) and adipic (C6 , 57.8 ng m-3 ) acids . Relatively high abundances of Ph and tPh differed from the distribution in urban and marine aerosols, indicating contributions from nearby anthropogenic sources. Glyoxylic acid (ωC2 , 41.4 ng m-3 ) was the dominant oxoacid, followed by 9-oxononanoic (ωC9 , 40.8 ng m-3 ) and pyruvic (Pyr, 24.1 ng m-3 ) acids. Glyoxal (Gly, 35.5 ng m-3 ) was the dominant α-dicarbonyl. Highest average concentrations were found for C2 , ωC2 and C9 in autumn, for C4 , Pyr and C6 in spring, for Ph, ωC9 and Gly in summer, while the lowest values were observed in winter. Seasonal variations and correlation coefficients of DARCs demonstrate that both primary emissions and secondary production are important sources. Principal component analysis of selected DARCs species suggests that a mixing of air masses from anthropogenic and biogenic sources contribute to the HS aerosols.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app